Medline Inc. MDLN
NASDAQ
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 12.07% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 12.07% | -- | -- | -- |
| Cost of Revenue | -- | 14.27% | -- | -- | -- |
| Gross Profit | -- | 6.22% | -- | -- | -- |
| SG&A Expenses | -- | 11.34% | -- | -- | -- |
| Depreciation & Amortization | -- | 1.73% | -- | -- | -- |
| Other Operating Expenses | -- | 39.58% | -- | -- | -- |
| Total Operating Expenses | -- | 13.44% | -- | -- | -- |
| Operating Income | -- | -3.18% | -- | -- | -- |
| Income Before Tax | -- | -6.25% | -- | -- | -- |
| Income Tax Expenses | -- | 135.19% | -- | -- | -- |
| Earnings from Continuing Operations | -- | -12.47% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -21.27% | -- | -- | -- |
| EBIT | -- | -3.18% | -- | -- | -- |
| EBITDA | -- | -1.15% | -- | -- | -- |
| EPS Basic | -- | 1,204.24% | -- | -- | -- |
| Normalized Basic EPS | -- | 2,882.73% | -- | -- | -- |
| EPS Diluted | -- | 1,185.15% | -- | -- | -- |
| Normalized Diluted EPS | -- | 2,877.27% | -- | -- | -- |
| Average Basic Shares Outstanding | -- | 109.61% | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | 4.82% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -0.55% | -- | -- | -- |